Journal of Bone Oncology

Papers
(The TQCC of Journal of Bone Oncology is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Epidemiology of spinal metastases, metastatic epidural spinal cord compression and pathologic vertebral compression fractures in patients with solid tumors: A systematic review53
Separation surgery for metastatic epidural spinal cord compression: A qualitative review50
Limb-salvage surgery offers better five-year survival rate than amputation in patients with limb osteosarcoma treated with neoadjuvant chemotherapy. A systematic review and meta-analysis42
New perspective into mesenchymal stem cells: Molecular mechanisms regulating osteosarcoma41
Updated guidance on the management of cancer treatment-induced bone loss (CTIBL) in pre- and postmenopausal women with early-stage breast cancer36
Baicalin induces apoptosis and autophagy in human osteosarcoma cells by increasing ROS to inhibit PI3K/Akt/mTOR, ERK1/2 and β-catenin signaling pathways32
Experience with denosumab (XGEVA®) for prevention of skeletal-related events in the 10 years after approval30
Guidance for the assessment and management of prostate cancer treatment-induced bone loss. A consensus position statement from an expert group29
Current strategies for the treatment of solitary and aneurysmal bone cysts: A review of the literature28
Targeting ferroptosis in osteosarcoma26
Adoptive transfer of TILs plus anti-PD1 therapy: An alternative combination therapy for treating metastatic osteosarcoma24
Malignancy in giant cell tumor of bone in the extremities24
The HMGB1/RAGE axis induces bone pain associated with colonization of 4T1 mouse breast cancer in bone22
Bone cement as a local chemotherapeutic drug delivery carrier in orthopedic oncology: A review19
Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal co18
Luteolin attenuates the chemoresistance of osteosarcoma through inhibiting the PTN/β-catenin/MDR1 signaling axis by upregulating miR-38418
Osteoporosis management in hematologic stem cell transplant recipients: Executive summary18
Role of microRNAs in the crosstalk between osteosarcoma cells and the tumour microenvironment18
LncRNA SNHG16 promotes epithelial-mesenchymal transition by upregulating ITGA6 through miR-488 inhibition in osteosarcoma18
Neurological outcomes after surgery for spinal metastases in symptomatic patients: Does the type of decompression play a role? A comparison between different strategies in a 10-year experience18
Primary bone lymphoma: Clinical presentation and therapeutic considerations17
Prediction of the early recurrence in spinal giant cell tumor of bone using radiomics of preoperative CT: Long-term outcome of 62 consecutive patients17
One oncogene, several vulnerabilities: EWS/FLI targeted therapies for Ewing sarcoma17
Sensory nerves: A driver of the vicious cycle in bone metastasis?16
The P2RX7B splice variant modulates osteosarcoma cell behaviour and metastatic properties16
In vitro three-dimensional cell cultures for bone sarcomas15
Giant cell tumor of bone: A single center study of 115 cases15
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference?15
MiR-451a promotes cell growth, migration and EMT in osteosarcoma by regulating YTHDC1-mediated m6A methylation to activate the AKT/mTOR signaling pathway15
All bone metastases are not created equal: Revisiting treatment resistance in renal cell carcinoma14
Periacetabular reconstruction following limb-salvage surgery for pelvic sarcomas14
Development and validation of a cuproptosis-related lncRNA model correlated to the cancer-associated fibroblasts enable the prediction prognosis of patients with osteosarcoma14
Real-world practice patterns and attitudes towards de-escalation of bone-modifying agents in patients with bone metastases from breast and prostate cancer: A physician survey13
Targeting the IGF/PI3K/mTOR pathway and AXL/YAP1/TAZ pathways in primary bone cancer13
Denosumab versus zoledronic acid in cases of surgically unsalvageable giant cell tumor of bone: A randomized clinical trial13
Surgical outcomes of metastatic bone tumors in the extremities (Surgical outcomes of bone metastases)13
c-Met expression in renal cell carcinoma with bone metastases13
Potential diagnostic value of circulating miRNA for multiple myeloma: A meta-analysis12
Prediction of vertebral fractures in cancer patients undergoing hormone deprivation therapies: Reliability of WHO fracture risk assessment tool (FRAX) and bone mineral density in real-life clinical pr12
Using a combination of gangliosides and cell surface vimentin as surface biomarkers for isolating osteosarcoma cells in microfluidic devices12
External validation of a genitourinary cancer-specific prognostic scoring system to predict survival for patients with bone metastasis (modified B-FOM scoring model): Comparison with other scoring mod12
ELF1-activated FOXD3-AS1 promotes the migration, invasion and EMT of osteosarcoma cells via sponging miR-296-5p to upregulate ZCCHC312
Chondroblastoma: Is intralesional curettage with the use of adjuvants a sufficient way of therapy?12
Primary perivascular epithelioid cell tumor (PEComa) in bone: A review of the literature and a case arising in the humerus with multiple metastases11
Management of bone metastasis and cancer treatment-induced bone loss during the COVID-19 pandemic: An international perspective and recommendations11
Delay in diagnosis of primary osteosarcoma of bone in children: Have we improved in the last 15 years and what is the impact of delay on diagnosis?11
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis10
m6A-dependent upregulation of TRAF6 by METTL3 is associated with metastatic osteosarcoma10
Hsa_circ_0010220 regulates miR-198/Syntaxin 6 axis to promote osteosarcoma progression10
von Willebrand factor promotes platelet-induced metastasis of osteosarcoma through activation of the VWF-GPIb axis10
Risk factors associated with skeletal-related events following discontinuation of denosumab treatment among patients with bone metastases from solid tumors: A real-world machine learning approach10
Bone metastases from urothelial carcinoma. The dark side of the moon10
CircRERE confers the resistance of multiple myeloma to bortezomib depending on the regulation of CD47 by exerting the sponge effect on miR-152-3p10
Identifying biomolecules and constructing a prognostic risk prediction model for recurrence in osteosarcoma10
Epidemiology and detection of cement leakage in patients with spine metastases treated with percutaneous vertebroplasty: A 10-year observational study10
Management of bone metastasis with zoledronic acid: A systematic review and Bayesian network meta-analysis9
Long non-coding RNA BLACAT1 expedites osteosarcoma cell proliferation, migration and invasion via up-regulating SOX12 through miR-6089
Serum total periostin is an independent marker of overall survival in bone metastases of lung adenocarcinoma9
Desmoplastic fibroma of the jaw bones: A series of twenty-two cases9
Chemotherapy in the management of periosteal osteosarcoma: A narrative review9
A predictive biomarker panel for bone metastases: Liquid biopsy approach9
The patterns of distant metastasis and prognostic factors in patients with primary metastatic Ewing sarcoma of the bone9
Long-non-coding RNA RUSC1-AS1 accelerates osteosarcoma development by miR-101-3p-mediated Notch1 signalling pathway8
Down-regulation of circular RNA hsa_circ_0007534 suppresses cell growth by regulating miR-219a-5p/SOX5 axis in osteosarcoma8
Evaluation of local and circulating osteopontin in malignant and benign primary bone tumors8
HDAC inhibitors stimulate LIFR when it is repressed by hypoxia or PTHrP in breast cancer8
Identification of GPC3 mutation and upregulation in a multidrug resistant osteosarcoma and its spheroids as therapeutic target8
Does vitamin D deficiency predict tumour malignancy in patients with bone tumours? Data from a multi-center cohort analysis8
BAIAP2L2 promotes the proliferation, migration and invasion of osteosarcoma associated with the Wnt/β-catenin pathway8
The role of intraoperative cell salvage for musculoskeletal sarcoma surgery8
Two-year results of a randomised trial comparing 4- versus 12-weekly bone-targeted agent use in patients with bone metastases from breast or castration-resistant prostate cancer8
Expression profiling of DNA methyl transferase I (DNMT1) and efficacy of a DNA-hypomethylating agent (decitabine) in combination with chemotherapy in osteosarcoma8
Lipopolysaccharide-binding protein expression is associated to the metastatic status of osteosarcoma patients8
Pre-operative prognostic nutritional index was associated with recurrence after surgery in giant cell tumor of bone patients8
Improved osteosarcoma survival with addition of mifamurtide to conventional chemotherapy – Observational prospective single institution analysis8
Inferior outcome of bone metastasis in non-small-cell-lung-cancer patients treated with epidermal growth factor receptor inhibitors7
Quality of resection margin with patient specific instrument for bone tumor resection7
Comprehensive multi-omics analysis reveals m7G-related signature for evaluating prognosis and immunotherapy efficacy in osteosarcoma7
Deep learning-based magnetic resonance imaging of the spine in the diagnosis and physiological evaluation of spinal metastases7
EFEMP1 binds to STEAP1 to promote osteosarcoma proliferation and invasion via the Wnt/β-catenin and TGF-β/Smad2/3 signal pathways7
Circular RNA circANKIB1 promotes the progression of osteosarcoma by regulating miR-217/PAX3 axis7
Application of “omics” sciences to the prediction of bone metastases from breast cancer: State of the art7
Outcomes and prognostic factors after surgery for bone metastases in the extremities and pelvis: A retrospective analysis of 140 patients7
0.045138120651245